Type
. Sulfanilamide in the treatment of leprosy. 1942. Public health reports (Washington, D.C. : 1974). 2006;121 Suppl 1:221-3; discussion 220.
Type
. Olfactory dysfunction in leprosy. The Laryngoscope. 2006;116(3):413-6.
Type
. The expression of RAGE and EN-RAGE in leprosy. The British journal of dermatology. 2006;154(4):594-601.
Type
. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clinical and vaccine immunology : CVI [Internet]. 2006;13(3):333-40. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1391965/pdf/0365-05.pdf
Type
. Genetic susceptibility to mycobacterial disease in humans. Immunology and cell biology. 2006;84(2):125-37.
Type
. Coming in from the cold. BMJ (Clinical research ed.) [Internet]. 2006;332(7540):508. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1388123/pdf/bmj33200508.pdf
Type
. Genetic host resistance and susceptibility to leprosy. Microbes and infection. 2006;8(4):1124-31.
Type
. The role of BCG in prevention of leprosy: a meta-analysis. The Lancet. Infectious diseases. 2006;6(3):162-70.
Type
. The surgical management of deformities of the hand in leprosy. The Journal of bone and joint surgery. British volume. 2006;88(3):290-4.
Type
. Opponens plasty rehabilitation protocol--a case report. Journal of hand therapy : official journal of the American Society of Hand Therapists. 2006;19(1):28-32, quiz 33.
Pagination
- Previous page
- Page 1993
- Next page